Evolent Operating Margin from 2010 to 2026
| EVH Stock | USD 2.79 0.15 5.68% |
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 148.7 M, Total Revenue of 3.1 B or Gross Profit of 443.6 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0072 or PTB Ratio of 1.22. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
Evolent | Operating Margin | Build AI portfolio with Evolent Stock |
The Operating Margin trend for Evolent Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Evolent Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Evolent Health's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Evolent Health over the last few years. It is Evolent Health's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Evolent Operating Margin Regression Statistics
| Arithmetic Mean | (0.64) | |
| Geometric Mean | 0.16 | |
| Coefficient Of Variation | (136.22) | |
| Mean Deviation | 0.66 | |
| Median | (0.28) | |
| Standard Deviation | 0.87 | |
| Sample Variance | 0.75 | |
| Range | 2.3534 | |
| R-Value | 0.81 | |
| Mean Square Error | 0.27 | |
| R-Squared | 0.66 | |
| Significance | 0.000068 | |
| Slope | 0.14 | |
| Total Sum of Squares | 11.98 |
Evolent Operating Margin History
About Evolent Health Financial Statements
Investors use fundamental indicators, such as Evolent Health's Operating Margin, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 3500 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Evolent Health Correlation against competitors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is there potential for Health Care Technology market expansion? Will Evolent introduce new products? Factors like these will boost the valuation of Evolent Health. Projected growth potential of Evolent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
Understanding Evolent Health requires distinguishing between market price and book value, where the latter reflects Evolent's accounting equity. The concept of intrinsic value - what Evolent Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Evolent Health's price substantially above or below its fundamental value.
It's important to distinguish between Evolent Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolent Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evolent Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.